Evidence map›Paper›PMID 42423707›Full record

ArticlePsychological assessment2026

Testing measurement invariance of the Brief Symptom Inventory across race, sex, and time among adults with cocaine use disorder.

Melissa R Schick, Yudilyn Jaramillo, Brian D Kiluk, Charla Nich, Donna LaPaglia, Angela M Haeny

Abstract read
In one paragraph

Article in Psychological assessment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Melissa R SchickDepartment of Psychiatry, Yale School of Medicine, Yale University.ORCID 0000-0003-0689-6672
Yudilyn JaramilloDepartment of Psychiatry, Yale School of Medicine, Yale University.
Brian D KilukDepartment of Psychiatry, Yale School of Medicine, Yale University.
Charla NichDepartment of Psychiatry, Yale School of Medicine, Yale University.
Donna LaPagliaDepartment of Psychiatry, Yale School of Medicine, Yale University.
Angela M HaenyDepartment of Psychiatry, Yale School of Medicine, Yale University.

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
Research Training Program in Substance Use PreventionT32DA019426 · NIDA · YALE UNIVERSITY · PI TAMI P SULLIVAN · 2005 to 2026
$7.5M
Mentoring Emerging Scientists for Careers in Substance Use ResearchR25DA035163 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carmen L Masson, Gideon St.Helen · 2014 to 2026
$4.6M
Computer-Based Training in Cognitve Behavioral TherapyR37DA015969 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 2003 to 2009
$2.6M
Maximizing CBT's Efficacy with Medication &CMR01DA019078 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 2005 to 2009
$1.6M
Understanding Race-Related Stress as a Mechanism Associated with Alcohol Craving to Inform Culturally-Adapting Alcohol Treatment for Black AdultsK23AA028515 · NIAAA · YALE UNIVERSITY · PI HAENY, ANGELA MARIA · 2021 to 2025
$969k
Leveraging Mobile Technology to Explicate the Role of Emotions in Substance Use Among Trauma-Exposed Community AdultsK23DA059609 · NIDA · YALE UNIVERSITY · PI Melissa R Schick · 2024 to 2026
$584k
NIAAA NIH HHS K23 AA028515NIDA NIH HHS K23 DA059609NIDA NIH HHS P50 DA009241NIDA NIH HHS R01 DA019078NIDA NIH HHS R25 DA035163NIDA NIH HHS R37 DA015969NIDA NIH HHS T32 DA019426NIH HHS
6 · The paper itself

Abstract

The Brief Symptom Inventory (BSI) is a commonly used measure to understand the influence of psychological distress on substance use treatment outcomes. However, few studies have examined whether the BSI functions equivalently across groups to allow for interpretable comparisons among individuals who use substances. The present study evaluated measurement invariance of the full 53-item BSI and the BSI-18 across race, sex, and time among individuals with cocaine use disorder. Data from seven clinical trials evaluating behavioral and/or pharmacological treatments for cocaine use were combined, providing a total sample of 629 participants with

Identifiers

PMID42423707
PMCPMC13353193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.